← Leaderboards
Nicholas M Boulis
Cleveland Clinic Foundation
$5,898,152
Attributed
$10,652,727
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,652,727 · 8
By mechanism
R01$8,240,439 · 4
R21$815,555 · 2
K08$799,157 · 1
K02$797,576 · 1
Top collaborators
- Younan Xia7 shared
- Peter D Canoll6 shared
- Eva L Feldman6 shared
- Jonathan David Glass6 shared
- Seward B Rutkove6 shared
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- William A Smith$9,331,329
Others in their field
Top investigators on “Spinal Cord”
- William G Barsan · University Of Michigan At Ann Arbor$41,978,947
- Martyn D Goulding · Salk Institute For Biological Studies$29,923,021
- P. Hunter Peckham · Case Western Reserve University$26,617,663
- Aron S Buchman · Rush University Medical Center$24,245,202
- Mark H Tuszynski · University Of California, San Diego$22,931,521
- Gordon Stewart Mitchell · University Of Florida$21,771,368
Research focus
Spinal CordOperative Surgical ProceduresMotor NeuronsLesionResearch PersonnelAnimalsDesignCellsAnatomyPre-ClinicalAffectInjection Of Therapeutic AgentSafetyNeuronsVectorEffective TherapyBaseMediatingPainDoseGenesPeripheral NervesClinicCharacteristics
Grant awards (33)
Lentiviral-Induced Swine Model of Spinal Cord Glioma$530,581
R01 · FY2025 · CA · contact PI
Hierarchically-Structured Conduits with Programmed Release of Neurotrophic Factors for Repairing Large Defects in Thick Nerves$440,388
R01 · FY2025 · NS
Lentiviral-Induced Swine Model of Spinal Cord Glioma$500,723
R01 · FY2024 · CA · contact PI
Hierarchically-Structured Conduits with Programmed Release of Neurotrophic Factors for Repairing Large Defects in Thick Nerves$391,821
R01 · FY2024 · NS
Supplement: Lentiviral-Induced Swine Model of Spinal Cord Glioma - Tumor Microenvironment in IDH-Mutations Low-Grade Glioma$172,375
R01 · FY2024 · CA · contact PI
Lentiviral-Induced Swine Model of Spinal Cord Glioma$522,370
R01 · FY2023 · CA · contact PI
Hierarchically-Structured Conduits with Programmed Release of Neurotrophic Factors for Repairing Large Defects in Thick Nerves$339,411
R01 · FY2023 · NS
Lentiviral-Induced Swine Model of Spinal Cord Glioma$598,912
R01 · FY2022 · CA · contact PI
Lentiviral-Induced Swine Model of Spinal Cord Glioma$541,702
R01 · FY2021 · CA · contact PI
Nanofiber Conduits with a Honeycomb Structure for Repairing Large Defects in Thick Nerves$463,296
R01 · FY2018 · EB
Nanofiber Conduits with a Honeycomb Structure for Repairing Large Defects in Thick Nerves$423,233
R01 · FY2017 · EB
Nanofiber Conduits with a Honeycomb Structure for Repairing Large Defects in Thick Nerves$456,996
R01 · FY2016 · EB
Phase 1b Trial of stem cells in ALS$709,886
R01 · FY2015 · NS
Nanofiber Conduits with a Honeycomb Structure for Repairing Large Defects in Thick Nerves$321,210
R01 · FY2015 · EB
Phase 1b Trial of stem cells in ALS$54,673
R01 · FY2015 · NS
Phase 1b Trial of stem cells in ALS$36,505
R01 · FY2015 · NS
Phase 1b Trial of stem cells in ALS$577,888
R01 · FY2014 · NS
Intrathecal Gene Therapy Expressing IGF-1 for Amyotrophic Lateral Sclerosis$193,050
R21 · FY2014 · NS · contact PI
Phase 1b Trial of stem cells in ALS$562,841
R01 · FY2013 · NS
Intrathecal Gene Therapy Expressing IGF-1 for Amyotrophic Lateral Sclerosis$195,000
R21 · FY2013 · NS · contact PI
Phase 1b Trial of stem cells in ALS$595,628
R01 · FY2012 · NS
Gene-based Neuromodulation: A New Paradigm for Functional Neurosurgery$132,047
K02 · FY2012 · NS · contact PI
Gene-based Neuromodulation: A New Paradigm for Functional Neurosurgery$132,047
K02 · FY2011 · NS · contact PI
Adeno-associated Viral Vector Modification for Targeted Motor Neuron Therapy$226,029
R21 · FY2010 · NS · contact PI
Gene-based Neuromodulation: A New Paradigm for Functional Neurosurgery$177,966
K02 · FY2010 · NS · contact PI
Adeno-associated Viral Vector Modification for Targeted Motor Neuron Therapy$201,476
R21 · FY2009 · NS · contact PI
Gene-based Neuromodulation: A New Paradigm for Functional Neurosurgery$177,966
K02 · FY2009 · NS · contact PI
Gene-based Neuromodulation: A New Paradigm for Functional Neurosurgery$177,550
K02 · FY2008 · NS · contact PI
Targeted Motor Neuron Gene Delivery for Spasticity$150,407
K08 · FY2006 · NS · contact PI
Targeted Motor Neuron Gene Delivery for Spasticity$155,018
K08 · FY2005 · NS
Targeted Motor Neuron Gene Delivery for Spasticity$163,193
K08 · FY2004 · NS
Targeted Motor Neuron Gene Delivery for Spasticity$165,985
K08 · FY2003 · NS
Targeted Motor Neuron Gene Delivery for Spasticity$164,554
K08 · FY2002 · NS